Zeo ScientifiX, Inc., formerly known as Organicell Regenerative Medicine, Inc., is a publicly traded, clinical-stage biopharmaceutical company. It focuses on researching, developing, and manufacturing biological therapeutics derived from perinatal sources to treat degenerative diseases and support regenerative medicine applications.
Company Values
The company's primary differentiator is its proprietary perinatal-sourced biologic technology platform, which is supported by ethical sourcing practices and rigorous batch testing protocols to ensure product quality and chain-of-custody ethics.